Cross-sectional evaluation of prescription of valproate and other antiepileptic drugs to pregnant women

[1]  Duygun Altıntaş Aykan,et al.  Klinik farmakoloji teratoloji risk analizi ile gebelikte kardiyovasküler ilaç kullanımının güvenilirliği , 2019, Cukurova Medical Journal.

[2]  N. Nakasato,et al.  Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database , 2019, Pharmacoepidemiology and drug safety.

[3]  Malte A Karow,et al.  Expression of N471D strumpellin leads to defects in the endolysosomal system , 2018, Disease Models & Mechanisms.

[4]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[5]  P. Videbech,et al.  The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review , 2018, CNS Drugs.

[6]  A. Marson,et al.  Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children. , 2017, JAMA.

[7]  H. Çaksen,et al.  Fetal Valproate Syndrome. , 2017, Pediatrics and neonatology.

[8]  J. Bainbridge,et al.  Epilepsy during pregnancy: focus on management strategies , 2016, International journal of women's health.

[9]  P. Pennell.  Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts , 2016, Neurotherapeutics.

[10]  T. Fu,et al.  Status epilepticus associated with pregnancy: A cohort study , 2016, Epilepsy & Behavior.

[11]  G. Koren,et al.  Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry , 2015, Therapeutic drug monitoring.

[12]  Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions , 2015, Pharmacoepidemiology and drug safety.

[13]  L. Jong‐van den Berg,et al.  Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions , 2015, Pharmacoepidemiology and drug safety.

[14]  T. Tomson,et al.  Major congenital malformations in children of women with epilepsy , 2015, Seizure.

[15]  J. Graham,et al.  The teratogenicity of the newer antiepileptic drugs – an update , 2014, Acta neurologica Scandinavica.

[16]  B. Bermas.  Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy , 2014, Current opinion in rheumatology.

[17]  S. Lah,et al.  Pregnancy-related knowledge and information needs of women with epilepsy: A systematic review , 2014, Epilepsy & Behavior.

[18]  N. Delanty,et al.  Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  R. Davis,et al.  Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. , 2012, Paediatric and perinatal epidemiology.

[20]  T. Tomson,et al.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.

[21]  C. Schaefer.  Drug safety in pregnancy: Utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services , 2011, Congenital anomalies.

[22]  A. Ornoy.  Valproic acid in pregnancy: how much are we endangering the embryo and fetus? , 2009, Reproductive toxicology.

[23]  W. Hauser,et al.  Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): III. Vitamin K, folic acid, blood levels, and breast‐feeding , 2009, Epilepsia.

[24]  K. Meador,et al.  Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts , 2008, Epilepsy Research.

[25]  Y. Ergun,et al.  Maternal antibiotic exposure and fetal outcomes: is there evidence for teratogenicity? , 2019, Annals of Medical Research.

[26]  D. Aykan.  Hormonal Contraceptives: What If Exposed During Pregnancy? , 2019, Erciyes Medical Journal.

[27]  Y. Ergün,et al.  Teratogenic evaluation of drugs used by pregnant patients with gastrointestinal system diseases , 2018 .